drugs with tirzepatide Associated Lower POAG, OHT Risk Compared with Other GLP-1 Mounjaro and Zepbound Are No

To view or add a comment, sign in New Clinical Trial: Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter Intra-Abdominal Hypertension | Phase: N/A | Sponsor: Wake Forest University Health Sciences | The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the ty #clinicaltrials #healthcare #research #clinicalmetric To view or add a comment, sign in Ahead of Lp(a) Awareness Day , there was a great discussion published in the journal of clinical lipidology, about Lp(a) JCL roundtable: European perspective on comprehensive lipid management and cardiovascular health Lp(a) is a genetic risk factor that should be tested for in all adults, and used to inform overall risk assessment and treatment intensity

doi: 10.1002/1873-3468.13057

The difference between BPC-157 and TB-500 benefits is shown in the table below

Choi, K

Ultimately, the best option depends on your health goals, tolerance for injections, and medical history